Abstract The effects of the lipopolysaccharide (LPS) from Ochrobactrum intermedium was evaluated in sheep experimentally infected with Fasciola hepatica. Animals were divided into four groups: two treated with the LPS (T1/T2) and two controls (C1/C2). T1/C1 were slaughtered at 30 days postinfection (dpi) and T2/C2 at 85 dpi. Body weight and body condition were found higher in T1 and T2 than in controls, although differences were not significant. Treated sheep showed lower cumulative fecal egg count than controls (p<0.01). Levels of red blood cells (RBC), white blood cells, hemoglobin, and hematocrit (HCT) were higher in T1 and T2. Significant differences (p<0.05) in RBC and HCT were found between groups at 84 dpi. More severe macrocytic and hypochromic anemia was observed in C1 and C2 than in treated groups. Total protein and albumin values were higher in T1 and T2 (p<0.01) until 29 dpi. At the end of the trial, no significant differences were observed in hepatic enzymes, although gamma-glutamyl transferase and aspartate aminotransferase values were higher in C2, and alanine aminotransferase was higher in T2. At necropsy, the mean weight of liver, fibrosis in portal triads, and ganglion size were similar in all groups. The number and size of flukes was greater in C2 than in T2 (p<0.05). The histological examinations revealed a higher degree of parenchymatous fibrosis in T2 compared to C2 (p<0.05). The administration of LPS from O. intermedium increased the nonspecific resistance against F. hepatica in experimentally infected sheep.
Introduction
The common liver fluke Fasciola hepatica is the causative agent of fasciolosis, a zoonosis with economic implications. The infection is commonly acquired by the ingestion of herbage or water contaminated with metacercariae. Although ruminants are the main animals at risk, in some regions, F. hepatica is also an important human pathogen (Haroun and Hillyer 1986) . The consequences of fasciolosis in small ruminants include retarded growth and decreased milk and wool production, and the disease has negative effects on general animal health, including fertility.
The integrated control strategy in ruminants is based on combining anthelmintic treatments with hygiene and grazing control (Cordero del Campillo and Rojo-Vázquez 1999), including key elements such as nutrition, genetics, and host immunity. The administration of effective chemoprophylactic is vital, although their misuse has allowed the development of anthelmintic resistance (Prichard 1994) . The drug most widely used to control fasciolosis in sheep is triclabendazole, due to its high efficacy against both adult and immature flukes (Fairweather 2005; Brennan et al. 2007 ). However, resistance to this anthelmintic has been reported since 1995 (Overend and Bowen 1995; Dalton et al. 2003; Álvarez-Sánchez et al. 2006) . As a consequence, new formulations should be tested with the currently available drugs (Martínez-Valladares et al. 2010a) . Vaccines and immunostimulatory products should be considered as alternatives to anthelmintic therapy (Dalton and Mulcahy 2001) . These products may be becoming more acceptable in the light of increasing public concern regarding chemical residues in food and the environment (Mulcahy and Dalton 2001) .
The immune system can be manipulated directly by a vaccine, or nonspecifically through immunomodulation (Masihi and Lange 1988) . Multiple studies have focused on development of a suitable vaccine for fasciolosis based on enzymes including glutathione S-transferases (Sexton et al. 1990; Morrison et al. 1996) , cathepsin L/B cysteine peptidases (Mulcahy and Dalton 2001; Dalton et al. 1996) , leucine aminopeptidases (Piacenza et al. 1999) , and on fatty acid binding proteins (Muro et al. 1997; López-Abán et al. 1999) . The coadministration of these molecules with adjuvants can enhance the immunogenicity of vaccines (Coffman et al. 2010) by stimulating the protective immunity through antibodies and T cell production.
Immunomodulators (IMMs) are immunostimulating and/or immunosuppressive agents used to modify the host defense mechanisms, with the aim of controlling viral, bacterial, parasitic, and fungal disease (Masihi 2000) . IMMs can be classified as microbial (whole microbes and bacterial lysates), natural, synthetic (muramyl peptides, thymic hormones, peptide analogs, Isoprinosine, and glucans), and cytokine IMMs (interferon, tumor necrosis factor, colony stimulating factors, and interleukins) (Masihi 2000) . Lipopolysaccharide (LPS), a glycolipid of the cell membrane of Gram-negative bacteria, is a potent immunostimulating agent that induces cytokine production by monocytes and macrophages (Rietschel and Brade 1992) . It is composed of the lipid A and a polysaccharide chain. Strategies to improve its results are focused on modifying the characteristics of the lipid A (Van der Ley 2001). The administration of LPS from Escherichia coli has been associated with attenuated inflammation as a consequence of downregulation of macrophage response. However, repeat doses of this glycolipid have been found to lead to tolerance in mice (Erroi et al. 1993 ). Veremeichenko and Zdorovenko (2008) reported that the administration of high doses of LPS from Pseudomonas spp. can be damaging rather than beneficial to the organism. Appropriate doses of LPS preparations can induce multiple beneficial effects, including adjuvanticity, radioprotective activity, and increased nonspecific resistance to infection and tumors (Dreisbach et al. 2000) .
Studies have shown the successful action of the LPS from E. coli as an IMM in experimental infections by gastrointestinal nematodes (GIN) in sheep (Abel et al. 2009 ).
Lipopolysaccharide from E. coli K12 was shown effective in mice infected by E. coli (Vuopio-Varkila et al. 1988 ) and by Francisella tularensis (Dreisbach et al. 2000) . The objective of the current study was to analyze the clinical effects of LPS from Ochrobactrum intermedium in sheep experimentally infected with F. hepatica.
Materials and methods

Animals and experimental design
The study was carried out using 36.5-month-old Merino sheep obtained from a flock without history of liver fluke infection. Sheep were weighed 1 week before the beginning of the study and divided according to body weight (BW) into four homogeneous groups of nine. Prior to beginning the trial, sheep were treated with a single oral dose of triclabendazole and levamisole (Endex®, 10 mg/kg). No clinical signs of parasitic or infectious disease were observed, and fecal analyses (flotation, sedimentation, and larval migration) were negative in all animals.
Animals were infected on day 0 with 200 F. hepatica metacercariae (Ridgeway Research Ltd. Co., Lydney, UK), in a gelatin capsule administered with a dosing gun.
On days 2 and 16 postinfection (dpi), treated groups, T1 and T2, received a subcutaneous injection of 2 ml of IMM containing 6 μg/ml LPS from O. intermedium strain LMG3306 (Laboratorios Ovejero S.A., León, Spain) (Ovejero-Guisasola and Fresno-Escudero 2010). Control groups, C1 and C2, were injected with sterile saline solution following the same protocol as the treated groups. Groups C1 and T1 were slaughtered for examination at 30 dpi and C2 and T2 at 85 dpi, both through intravenous injection of a lethal dose (20 ml) of sodium pentobarbital (Dolethal, Vétoquinol S.A., France).
The study was carried out at the animal facilities of the Instituto de Ganadería de Montaña, León, Spain. Sheep were handled in accordance with animal ethics guidelines.
In vivo measurements
Throughout the study until its conclusion at 85 dpi, BW and body condition (BC) were measured every 2 weeks. BC was evaluated according to a system of scoring from 0 to 5 described by Russel et al. (1969) . Scoring was done by a single individual to ensure consistency.
Clinical parameters such as general health status, apathy, abdominal distress, and anemia were evaluated at 0, 1, 3, and 7 dpi and, subsequently, weekly until the end of the trial.
Fecal samples were taken directly from rectum three times per week from 42 to 85 dpi. The cumulative fecal egg count (FEC) was calculated according to Vercruysse et al. (1993) . The number of F. hepatica eggs was calculated by a standard sedimentation method using a McMaster chamber (Thienpont et al. 1986 ).
Hematological and biochemical parameters
Blood samples were taken by jugular venipuncture using 5 ml EDTA Venoject vacuum tubes (BD vacutainers) and 5 ml Venoject vacuum tubes without anticoagulant to obtain serum, at the time of assessing clinical parameters. The samples were processed immediately, using an automated hematology cell analyzer Medonic CA 530 (Boule Diagnostics AB, Sweden) to determine the following hematological parameters: red blood cells (RBC), white blood cells (WBC), hemoglobin level (HB), hematocrit (HCT), mean corpuscular volume (MCV), and mean corpuscular hemoglobin concentration (MCHC).
Serum samples were analyzed at the Laboratorio de Técnicas Instrumentales of the University of León. The levels of total protein (TP), albumin (ALB), and the hepatic enzymes gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) were determined.
Necropsy
A necropsy on all sheep was conducted according to standard procedures. The livers were weighed and scored from 0 to 5 points, depending on level of macroscopic lesions (0: absence of lesions in tissue; 5: severe proliferation of fibrous connective tissue). Immature and mature flukes present in the liver and gallbladder were recovered. In groups C1 and T1 (30 dpi), the liver tissue was cut into 25 cm 3 cubes, macerated, and passed through a 300 μm sieve to recover immature flukes (Clery et al. 1996; Haçariz et al. 2009 ). At necropsy of groups C2 and T2 (85 dpi), the main bile ducts on the liver surface were opened, the liver was squeezed manually to release flukes, and all flukes were collected into physiological saline solution. The liver was cut into 1-2 cm slices, squeezed to release the remaining mature flukes, and macerated as described (Clery et al. 1996) . Immature and mature flukes were counted and classified according to size. For C1 and T1, the categories were <2, 2.1-3.5, and 3.6-6 mm. At the second necropsy, categories were 1-5, 5-10, and >10 mm. Counts also included any identified fluke heads and tails; whichever was found in higher numbers (heads or tails) was included in the total count.
The hepatic lymph nodes (HLNs) were recovered and scored from 0 to 10 according to relative size.
For sheep in groups C2 and T2, the presence of fecal occult blood (FOB) was analyzed by a single slide stool blood test (Cenogenics Co., USA) at the conclusion of the trial.
Histopathology
Samples of liver and HLN were fixed in 10 % buffered formalin for at least 24 h at room temperature, embedded in paraffin, cut into 4 μm sections, and stained with hematoxylin and eosin. The hepatic lesions were classified as portal fibrosis, parenchymatous necrosis, hyperplasia of bile ducts, and presence of inflammatory cells in portal and parenchymatous areas. The HLNs were studied to assess the degree of lesion in the cortex (number and size of the lymphoid follicles and infiltration of subcapsular sinus by inflammatory cells), paracortex (size, infiltration), and medulla (loss of structure and infiltration).
All lesions were visually scored as follows: 0: negative, 1: moderate, 2: severe, and 3: very severe.
Statistical analysis
Data were analyzed using the statistical package SPSS for Windows. FEC was transformed to Ln (X+1) to produce approximately normally distributed data. The comparative analyses among groups were performed by analysis of variance. Differences were considered significant p<0.05.
Results
In group C2, three animals were eliminated from the trial due to infection failure; therefore this group included only six sheep.
In vivo measurements
At the conclusion of the trial, treated groups showed higher BW and BC than control groups (Fig. 1) . Differences did not reach levels of significance in any case.
Clinical signs (general health status, apathy, fever, abdominal distress, and anemia) showed no differences between treated and control groups (data not shown). No mortality or adverse effects of administration of the LPS or the saline solution were observed.
Eggs were first detected in feces at 49 dpi in group T2. Significant differences between treated animals and controls were shown at 66 and 69 dpi (p<0.01) and at 78 and 80 dpi (p<0.05), with higher values in C2. At the end of the study, the mean cumulative FEC in C2 and T2 was 1,193.8 eggs per gram (±424.5) and 608.4 (±251.8), respectively, (p<0.01) (Fig. 2) . Hematological parameters RBC: In both treated and control groups, RBC values decreased gradually from the beginning of the study. In treated groups, parameters were found within the normal range (11-13×10 6 /μl) (Schalm et al. 1981 ) throughout the study with the exception of 70 and 77 dpi, when values dropped to 10-11×10 6 /μl. In the controls, values were normal until 36 dpi, decreasing thereafter to 9-11×10 6 /μl (Table 1) . At 84 dpi, values were significantly higher in T2 than in C2 (p<0.05).
WBC: Values were above the normal range (2.5-7.5× 10 3 /μl) (Schalm et al. 1981) in both control and treated groups during the trial (Table 1) . Although WBC values were similar among groups, T2 showed higher values at the end of the study in comparison to C2, but differences were not significant.
HB: All groups were within the normal range (11-13 g/dl) (Schalm et al. 1981) , with the exception T2 at 70 dpi and C2 at 77 and 84 dpi (Table 1) . In both controls and treated groups, HB values were lower at the end of the study. There were no observed significant differences among groups throughout the trial.
HCT: This parameter remained within the normal range (30-45 %) (Schalm et al. 1981) . All groups showed highest values (44-47 %) during the first week pi (Table 1 ). The kinetics of the HCT was similar among groups, with T2 showing higher percentages at 84 dpi (p<0.05).
MCV and MCHC: The normal range (30-38 fl) (Schalm et al. 1981) of MCV (HCT×10/RBC) values was exceeded in C1/C2 and T1/T2, at 34.5-39.9 fl and 34.5-38.5 fl, respectively. Significantly higher values were measured in controls compared to treated groups at 3 dpi (p<0.01) and at 70 dpi (p<0.05). All groups showed MCHC (HB×100/HCT) values below the normal range (31-33 g/dl), ranging from 25.7-30.5 and 26.0-29.2 g/dl in control and treated groups, respectively. Differences were not significant. All groups exhibited macrocytic and hypochromic anemia, which was more severe in the control groups, although without significance (data not shown). Biochemical parameters
TP and ALB
TP levels were within the normal range (6-7.5 g/dl) (Benjamín 1984) , with the exceptions of 3, 7, 13, and 21 dpi in controls, and at 1, 7, and 70 dpi in treated groups, when values fell below the normal range. In both treated and control groups, this parameter rose above the normal range at 49 dpi. Significant differences between treated and controls were observed at 3 and 21 dpi (p<0.01) and 13 and 29 dpi (p<0.05), with higher values in treated groups (Fig. 3a) . ALB values were within normal limits (2.7-3.7 g/dl) (Benjamín 1984) , except at 42 and 49 dpi in C1 and C2 and at 49 dpi in T1 and T2, when values exceeded the upper limit. Values below normal were found in C1/C2 at 3 and 13 dpi and in T2 at 70 dpi. Significant differences between groups were found at 3, 13, 21, and 29 dpi (p<0.01), with higher values in treated groups, and at 42 and 70 dpi (p<0.01) and 49 dpi (p<0.05), with higher values in C2 (Fig. 3b) .
Hepatic enzymes (GGT/AST/ALT)
GGT values at the end of the trial were 246.8(±157.6)IU/l in C2 and 193.6(±82.8)IU/l in T2, significantly higher than the reference values of 21-44 IU/l (Sykes et al. 1980; Kaneko 1980) . GGT levels in control and treated groups were consistently below 100 IU/l through 36 and 42 dpi, respectively, after which they increased. Maximum enzyme activity was observed at 63 dpi, with values above the mean of 123.2 % in C2 and 101.6 % in T2. Significant differences were observed at 3, 21, and 29 dpi (p<0.01) and 13 dpi (p<0.05), with higher values in treated groups, and at 56 dpi (p<0.05), with higher values in C2 (Fig. 3c) .
AST values were 260.1 (±137.1) and 172.7(±38.2)IU/l in C2 and T2, respectively, at the end of the study, both significantly higher than the normal range of 27-70 IU/l (Kaneko 1980; Sykes et al. 1980) . Levels increased between 49 and 56 dpi, with values above the mean of 97.8 % in C2 and 84.5 % in T2. Values subsequently decreased until the end of the trial, when they reached values similar to those measured at 42 dpi. Values in T1/T2 were significantly higher than in the corresponding controls at 3, 13, and 21 dpi (p<0.01) (Fig. 3d) .
Throughout the trial, mean ALT was within normal limits (7-24 IU/l) (Benjamín 1984) , with slight increases in C2 and T1/T2 at 42 dpi and 21 dpi, respectively. ALT values were consistently within the normal range in all groups until the conclusion of study, when they fell below this range. Significant differences were shown at 3 and 21 dpi (p<0.01), with higher values in treated groups (Fig. 3e) .
Necropsy results
Mean liver weight was similar in C1 (0.8±0.2 kg) and T1 (0.9±0.1 kg), as well as in C2 (1.0±0.2 kg) and T2 (1.0±0.1 kg).
Superficial liver damage characterized by fibrous tracks was observed in both groups, with scores of 4.2 (±1.2) in C1 and 3.8 (±1.1) in T1. Hepatic damage scores were slightly lower in C2 (4.0±0.6) than in T2, 4.1 (±1.0).
HLN size values (0-10) were 5.9 (±1.4) and 6.0 (±1.7) in C1/T1 and C2/T2, respectively. Nonsignificant increases were found in C2 and T2 to 8.2 (±1.3) and 6.5 (±2.2), respectively.
The mean number of immature flukes recovered per sheep was 60.0 (±37.1) and 88.7 (±25.8) in C1 and T1, respectively. The mean number of adult flukes per animal in C2 and T2 was 128.7 (±41.7) and 95.4 (±26.4), respectively. Differences between control and treatment groups were significant (p<0.05) at both necropsies.
Flukes were classified according to size categories depending on necropsy group (Fig. 4a) . The mean number of flukes in each size category was similar, with the largest (>10 mm) recovered at the second necropsy, where significant differences were found (p<0.05). A significantly higher number of flukes of the largest size-range category were collected in C2 (91.7±32.1) compared with T2 (53.0±21.4) (Fig. 4b) .
All sheep were positive for the presence of blood in feces at 82 dpi.
Histopathology
Histological changes in liver included the presence of fibrocytes, fibroblasts, and collagen fibers; eosinophilic and leucocytic infiltration; bile duct proliferation and loss of lymphoid vessels in portal areas ( Fig. 5a and b) ; and areas of necrosis in the liver parenchyma. Infiltration of the lining epithelium was also observed (Fig. 5b) .
Livers of C1 showed higher degrees of fibrosis (1.4±1.1) and bile duct hyperplasia (2.6±0.5) compared 0.4 (±0.5) and 2.5 (±0.5), respectively, for T1. Inflammatory infiltration in portal triads was similar in among groups, with numbers of macrophages (1.1±0.4) and eosinophils (2.2±0.5) lower in C1 than in T1 (1.2±0.4 and 2.3±0.5, respectively). Significant differences between groups (p<0.05) were found only for fibrosis.
A greater degree of fibrosis was observed in T2 (2.3±0.6) than in C2 (2.0±0.9). Macrophage numbers were higher in C2 (1.8±1.0) than in T2 (1.7±0.5), and eosinophils were lower in T2 (1.8±1.3) than in C2 (2.0±1.3). No differences reached significance levels.
Necrotic foci were present in the hepatic lobules (Fig. 6a) . Levels of parenchymatous necrosis were similar in C1 (2.2±0.6) and T1 (2.2±0.7). Group T2 showed lower levels (1.8±1.2) than C2 (2.3±1.2). Macrophage numbers were slightly lower in C1 (1.4±0.5) than in T1 (1.7±0.7), in contrast to results seen in C2 (2.0±1.1) compared to T2 (1.6±1.0), in which the controls showed higher levels. Neutrophils were higher in treated groups at both necropsies, with values in T1 and T2 of 1.8 (±1.5) and 1.1 (±0.8), respectively, compared to 1.1±1.2 in C1 and 0.7±0.8 in C2. Eosinophil levels were similar in C1 (2.3±0.5) and T1 (2.3±0.7) but were slightly higher in C2 (1.7±1.5) compared to T2 (1.4±1.3). No differences reached significance levels.
The most notable alteration in HLNs, observed especially in T2, was an increase in the number and size of lymphoid follicles in the cortex, invading and modifying the paracortex and medullar structure. Lymphoid follicles possessed a wide germinal center consisting of immature cells, with wide cytoplasm surrounded by a crescent halo of mature lymphocytes (Fig. 6b) . Lymphoid follicles was slightly smaller in C2 (2.7±0.5) than in T2 (2.8±0.4), although the germinal center in C2 was larger (3.0±0.0) than in T2 (2.8±0.4). All sheep showed lymphocytic infiltration in the subcapsular sinus and an increase in the size of the paracortex (C2: 1.7±0.8; T2: 2.6±0.9) and the medulla (C2: 0.5±0.8; T2: 0.9±1.3). There were no significant differences between groups.
Discussion
The objective of the current study was to evaluate the IMM effects of LPS from O. intermedium on sheep experimentally infected with F. hepatica. The LPS from E. coli combined with killed Propionibacterium acnes has been previously used as an IMM for helminth control in sheep infected with GINs (Abel et al. 2009 ). The immune system can be specifically modified via the administration of vaccines with adjuvants. The adjuvants themselves have little immunogenicity but can enhance the immune response against the specific antigen, for which they are administered. IMMs exert their effect by boosting host immune responses rather than targeting pathogens directly and enhance host defenses both preventively and therapeutically (Nicholls et al. 2010) .
In the present study, the most notable finding was the significant decrease in FEC in treated groups. These results are similar to the effect reported using the adjuvant Quil A (Haçariz et al. 2009 ) in sheep experimentally infected with F. hepatica. Mendes et al. (2010a) described the protective action of Quil A as indicated by FEC in goats, especially when administered in combination with Peroxiredoxin. In contrast, the administration of other adjuvants such as Freund's incomplete adjuvant (FIA) and TiterMax Gold in sheep (Haçariz et al. 2009 ) and FIA coadministered with Freund's complete adjuvant in goats showed no effect on FEC levels in F. hepatica infection.
The increase in BW was constant throughout the study, in accordance with trials, in which Quil A, FIA, and TiterMax Gold were administered to sheep infected by F. hepatica. TiterMax Gold showed significantly greater BW values in comparison to the Quil A and FIA (Haçariz et al. 2009 ).
All hematological parameters were higher in treated groups. While WBC and HCT values remained within normal limits throughout the study, RBC counts were below the normal range at several test times, principally in the control groups. The macrocytic and hypochromic anemia observed was previously described (Martínez-Valladares et al. 2010b) in an experimental F. hepatica infection in sheep. At the conclusion of the trial, FOB was detected in all infected sheep. Chronic fasciolosis is also characterized by hypoproteinemia as a result of hypoalbuminemia (Cordero del Campillo and Rojo-Vázquez 1999).
Liver damage induced by F. hepatica can be confirmed by the determination of hepatic enzymes levels, particularly GGT (Ferre et al. 1996) , which is associated with penetration of migrating flukes into the bile ducts, leading to hyperplastic cholangitis (Massoud et al. 2001; Burke 2002) . Although GGT showed above normal levels in all groups, in C2, the increase was more pronounced beginning at 42 dpi. GGT remained elevated in the final half of the trial, as previously reported (Martínez-Valladares et al. 2010a; Haçariz et al. 2009; Buffoni et al. 2010; McConville et al. 2009 ). This suggests that bile duct damage was lower in animals treated with IMM, possibly as a consequence of smaller adult flukes. Similar results were found in AST levels, which is associated with the number of immature flukes (Severin et al. 2012 ) and an indicator of hepatic necrosis (Burke 2002) . AST values in C2 at the end of the study coincided with a higher level of parenchymatous necrosis. The ALT enzyme, more specific for hepatic necrosis than AST, was higher in treated groups until the first necropsy, due to the inflammatory state of the liver and tissue destruction as a consequence of the parenchymal migration of immature fluke stages during the first stage of fasciolosis (Ferre et al. 1994) . Groups C2 and T2 showed similar values until the end of the study.
The treatment with LPS of O. intermedium was associated with a significant reduction in adult fluke burden in group T2, in accord with lower cumulative FEC. The higher number of immature flukes in T1 compared to C1 could possibly reflect counting error, due to the difficulty in recovering these forms. Mendes et al. (2010b) tested the adjuvant Quil A in goats infected with F. hepatica and, despite the higher fluke burden in the control group, no significant differences in reduction of fluke numbers were found between the treated and the control group. In our study, it is noteworthy that the flukes recovered from T2 were significantly smaller than those from C2, suggesting that the LPS could have impaired the development of the flukes.
The only significant difference between treatment and controls in liver histology was observed in the level of fibrosis, higher in C1 and coinciding with more extensive hepatic damage. This fibrosis may restrict the movement of the flukes because of inflammation of the bile duct epithelia and areas of the parenchyma immediately adjacent (Behm and Sangster 1999) . Consequently, flukes recovered from T2 were smaller than those collected from C2. Inflammatory infiltrate consists of macrophages, eosinophils, and neutrophils and is present in recent hemorrhagic tracks (Martínez-Moreno et al. 1999) . The presence of fibrocytes and fibroblasts admixed with lymphocytes and mononuclear cells inside the portal triad was the result of migration of immature flukes, as reported in previous studies of goats (Talukder et al. 2010) . Macrophage and eosinophil presence in the portal triad was higher in T1 than in C1, while eosinophil levels were higher in C2, and, along with fibrosis, were the main factors in hepatic alteration occupying broad areas of parenchyma and destroying the tissue architecture. Proliferation of fibrous connective tissue associated with infiltration of lymphocytes in the portal area was lower in T1 than in C1 but was higher in T2, suggesting less hepatic damage at the beginning of the infection in treated groups, in accordance with previous reports in rats (Van Milligen et al. 1998; Kesik et al. 2007 ). Bile duct hyperplasia was lower in treated groups and may be due to the smaller size of the flukes in these groups, as Zafra et al. (2010) also pointed out in a study with goats. No calcification in the wall of the bile ducts was observed, as previously reported in sheep (Pullan et al. 1970 ) and goats (Talukder et al. 2010). There were no significant differences in the size of lymphatic vessels. Although parenchymatous necrosis was similar in both groups, the degree of necrosis was lower in T2, probably also due to smaller flukes.
Marked hyperplasia of HLN lymphoid follicles and medullary cords suggests a strong local humoral immune response (Zafra et al. 2009; and was higher in T2 at the end of the study. On the contrary, the greatest increase in the overall size of HLNs was seen in C2.
The oral administration of LPS from O. intermedium in sheep infected by F. hepatica led to a lower FEC in treated sheep, suggesting an effect on the number and the development of the flukes. Data obtained with respect to hepatic enzymes, as well as other biochemical and hematological values, indicated lower cholestasis and liver migration of immature flukes in treated groups. Group C1 exhibited significantly higher fibrosis levels and more severe necrosis compared to the treated group. While the mode of action of LPS from O. intermedium should be studied more extensively, this initial report suggests that an appropriate dose of this IMM can increase the nonspecific resistance to the infection and could be used as a possible adjuvant in vaccine formulations.
